CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04704921
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-29T13:31:47.670592+00:00
Published At: 2026-04-28T00:00:00+00:00
Record Updated At: 2026-04-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["AMD", "nAMD", "Wet Age-related Macular Degeneration", "wAMD", "Wet AMD", "CNV", "Neovascular AMD", "Neovascular Age-related Macular Degeneration", "Choroidal Neovascularization"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-28"
protocolSection.identificationModule.nctId: "NCT04704921"
protocolSection.identificationModule.officialTitle: "A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.